Biological mechanisms of cancer-related fatigue in breast cancer survivors after treatment: a scoping review

被引:16
作者
Garcia-Gonzalez, David [1 ]
Medino-Munoz, Juan [2 ]
Romero-Elias, Maria [3 ]
Garcia-Foncillas, Jesus [1 ,4 ,5 ]
Ruiz-Casado, Ana [3 ,6 ]
机构
[1] Univ Autonoma Madrid UAM, Sch Med, Madrid 28029, Spain
[2] Hosp Univ Fuenlabrada, Lib, Madrid 28942, Spain
[3] IDIPHISA, Inst Invest Sanitaria Puerta Hierro Segovia Arana, Madrid 28222, Spain
[4] IIS Fdn Jimenez Diaz, Oncohealth Inst, Translat Oncol Div, Madrid 28040, Spain
[5] UAM, Hosp Univ Fdn Jimenez Diaz, Dept Med Oncol, Madrid 28040, Spain
[6] Hosp Univ Puerta Hierro Majadahonda, IDIPHISA, Dept Med Oncol, Madrid 28222, Spain
关键词
Cancer-related fatigue; Biomarkers; Inflammation; Hypothalamo-hypophyseal system; Autonomic nervous system; Diet; METHYLTRANSFERASE GENOTYPE VAL158MET; INFLAMMATORY BIOMARKERS; PERSISTENT FATIGUE; GENE POLYMORPHISMS; RISK-FACTORS; CORTISOL; DISEASE; CHEMOTHERAPY; ASSOCIATION; VARIABILITY;
D O I
10.1007/s11764-023-01477-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeCancer-related fatigue (CRF) is the most common symptom experienced by cancer survivors. It is a multidimensional symptom affecting physical, emotional, and/or cognitive spheres, different from other types of fatigue. Characteristically is not alleviated by sleep or rest. CRF could have specific features in breast cancer survivors (BCS), because of sex, hormones, and distinct treatments. On the other hand, more than 25% of BCS report persistent CRF for 10 years or more after the diagnosis. The present study aims to recapitulate the knowledge about the biological mechanisms that potentially drive CRF in BCS after treatment.MethodsTo answer a broad question, a scoping review methodology was used. Data were collated from three bibliographic databases: PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL). Studies were selected if they had included more than 20 BCS, after finishing their treatment, fatigue was measured with a quantitative scale and biomarkers were analyzed.ResultsThe final database was composed of 1896 records. Sixty-four studies finally met the eligibility criteria. Inflammation (61%), hypothalamic-pituitary-adrenal (HPA) axis dysregulation (14%), autonomic nervous system (ANS) dysfunction (11%), and diet (9%) were the biological pathways most frequently studied. Unfortunately, results from studies about inflammation and HPA axis show many inconsistencies.ConclusionMore research about the role of ANS dysfunction and diet on the pathogenesis of CRF would be warranted according to the results of the review. There are some fields such as endocannabinoid systems, mitochondrial dysfunction, gut microbiota, and oxidative stress that have been insufficiently explored.Implications for Cancer SurvivorsTo widen the scope of future research in the physiopathology of CRF, it is necessary to identify mechanisms that would be potentially involved and have been insufficiently explored. Because of the high prevalence of CRF in BCS and the tremendous impact that fatigue has in their quality of life, it is essential to improve the efficacy of the treatments through a good knowledge of the biological basis of CRF.
引用
收藏
页码:414 / 444
页数:31
相关论文
共 97 条
[1]   Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors [J].
Abrahams, H. J. G. ;
Gielissen, M. F. M. ;
Schmits, I. C. ;
Verhagen, C. A. H. H. V. M. ;
Rovers, M. M. ;
Knoop, H. .
ANNALS OF ONCOLOGY, 2016, 27 (06) :965-974
[2]   Fatigue and its associated factors in ambulatory cancer patients: A preliminary study [J].
Akechi, T ;
Kugaya, A ;
Okamura, H ;
Yamawaki, S ;
Uchitomi, Y .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 17 (01) :42-48
[3]   A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome [J].
Alexander, S. ;
Minton, O. ;
Andrews, P. ;
Stone, P. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (03) :384-392
[4]   Fatigue, Inflammation, and ω-3 and ω-6 Fatty Acid Intake Among Breast Cancer Survivors [J].
Alfano, Catherine M. ;
Imayama, Ikuyo ;
Neuhouser, Marian L. ;
Kiecolt-Glaser, Janice K. ;
Smith, Ashley Wilder ;
Meeske, Kathleen ;
McTiernan, Anne ;
Bernstein, Leslie ;
Baumgartner, Kathy B. ;
Ulrich, Cornelia M. ;
Ballard-Barbash, Rachel .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) :1280-1287
[5]   Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: a longitudinal study [J].
Alhareeri, Areej A. ;
Archer, Kellie J. ;
Fu, Han ;
Lyon, Debra E. ;
Elswick, R. K., Jr. ;
Kelly, Debra L. ;
Starkweather, Angela R. ;
Elmore, Lynne W. ;
Bokhari, Yahya A. ;
Jackson-Cook, Colleen K. .
BREAST CANCER RESEARCH, 2020, 22 (01)
[6]   Prevalence, Predictors, and Characteristics of Off-Treatment Fatigue in Breast Cancer Survivors [J].
Andrykowski, Michael A. ;
Donovan, Kristine A. ;
Laronga, Christine ;
Jacobsen, Paul B. .
CANCER, 2010, 116 (24) :5740-5748
[7]   Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia? [J].
Bauml, Joshua ;
Chen, Lu ;
Chen, Jinbo ;
Boyer, Jean ;
Kalos, Michael ;
Li, Susan Q. ;
DeMichele, Angela ;
Mao, Jun J. .
BREAST CANCER RESEARCH, 2015, 17
[8]   Fatigue and resting-state functional brain networks in breast cancer patients treated with chemotherapy [J].
Bekele, Biniam Melese ;
Luijendijk, Maryse ;
Schagen, Sanne B. ;
de Ruiter, Michiel ;
Douw, Linda .
BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (03) :787-796
[9]   Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue [J].
Bower, JE ;
Ganz, PA ;
Aziz, N .
PSYCHOSOMATIC MEDICINE, 2005, 67 (02) :277-280
[10]   Diurnal cortisol rhythm and fatigue in breast cancer survivors [J].
Bower, JE ;
Ganz, PA ;
Dickerson, SS ;
Petersen, L ;
Aziz, M ;
Fahey, JL .
PSYCHONEUROENDOCRINOLOGY, 2005, 30 (01) :92-100